General
Preferred name
ORPHENADRINE CITRATE
Synonyms
Banflex ()
Flexon ()
Flexoject ()
Orphenadrine (citrate) ()
Norflex ()
Orphenadine Citrate ()
Orphenadrine dihydrogen citrate ()
NSC-757238 ()
P&D ID
PD001824
CAS
4682-36-4
83-98-7
4596-23-0
4724-58-7
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antihistaminic
Relaxant (skeletal muscle)
First approval
1959
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
AdooQ Bioactive Compound Library
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Properties
(calculated by RDKit )
Molecular Weight
461.2
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
4
Rotatable Bonds
11
Ring Count
2
Aromatic Ring Count
2
cLogP
2.41
TPSA
144.6
Fraction CSP3
0.38
Chiral centers
1.0
Largest ring
6.0
QED
0.4
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Neuroscience
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
AChR
iGluR
Source data
